Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | LPL | P06858 | 1/20 | 0.32 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16951694 | 0.87 | FFAR4 (0.37) | CNR1CNR2SLC6A4NPC1HPGD | |
| SCHEMBL12410556 | 0.86 | HPGD (0.47) | PTGS2CYP3A4NPC1HPGDMAPK1 | |
| SCHEMBL16951691 | 0.85 | SLC6A4 (0.31) | CNR1CNR2SLC6A4 | |
| SCHEMBL16956233 | 0.85 | CNR1 (0.34) | CNR1CNR2SLC6A4PTGS2CYP3A4 | |
| SCHEMBL12410561 | 0.82 | PTGS2 (0.53) | SLC6A4PTGS2CYP3A4LPLLIPG | |
| SCHEMBL21727727 | 0.82 | PTGS2 (0.45) | PTGS2CYP3A4NPC1ALDH1A1 | |
| SCHEMBL16960311 | 0.82 | CNR1 (0.32) | CNR1CNR2 | |
| SCHEMBL16955227 | 0.80 | THRB (0.32) | — | |
| SCHEMBL9886162 | 0.80 | IDO1 (0.35) | SLC6A4NPSR1ALDH1A1 | |
| SCHEMBL16956230 | 0.80 | CNR1 (0.32) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2334661-B1 | PROCESSES FOR PREPARING POLY(PENTAFLUOROSULFANYL)AROMATIC COMPOUNDS | UBE INDUSTRIES (JP) | 2017-08-30 | — | — | EP | disclosed |
| US-8653302-B2 | Processes for preparing poly(pentafluorosulfanyl)aromatic compounds | UBE INDUSTRIES, LTD. (JP) | 2014-02-18 | — | — | US | disclosed |
| US-8653302-B2 | Processes for preparing poly(pentafluorosulfanyl)aromatic compounds | UBE INDUSTRIES, LTD. (JP) | 2014-02-18 | — | — | US | disclosed |
| US-20110166392-A1 | Processes for Preparing Poly(Pentafluorosulfanyl)Aromatic Compounds | UBE INDUSTRIES, LTD. (JP) | 2011-07-07 | — | — | US | disclosed |
| US-20110166392-A1 | Processes for Preparing Poly(Pentafluorosulfanyl)Aromatic Compounds | UBE INDUSTRIES, LTD. (JP) | 2011-07-07 | — | — | US | disclosed |
| WO-2010033930-A1 | PROCESSES FOR PREPARING POLY(PENTAFLUOROSULFANYL)AROMATIC COMPOUNDS | IM&T RESEARCH, INC. (US) | 2010-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166392-A1 | Processes for Preparing Poly(Pentafluorosulfanyl)Aromatic Compounds | PFAS, PUF60, FES | CNR1 4238/4885CNR2 4489/4885SLC6A4 1095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.